The FutureMed Program educates, informs and prepares physicians, innovators, inventors, investors and senior healthcare executives to understand and recognize the opportunities and disruptive influences of exponentially growing technologies within medicine and healthcare, and to understand how many rapidly developing and converging fields affect the future of clinical practice and the biomedical industry.
Philip Low, PhD is the CEO and Founder of NeuroVigil. NeuroVigil has built a device called iBrain, which is the first personal brain monitor used by patients in the home. This allows the healthcare professional to capture more data from the patient that will enable better decisions and outcomes by personalizing their treatment plan.
Watch more FutureMed Faculty synthesis videos here
Philip Low is Chairman and Chief Executive Officer of NeuroVigil, the award-winning wireless neurodiagnostics company headquartered in San Diego. At the University of Chicago, he invented novel neurosurgical techniques. At Harvard Medical School, he showed in 9 weeks that a collagen inhibitor could successfully neutralize the growth of fibroid tumors – he was 19 years old at the time. At the Salk Institute, he invented the SPEARS algorithm and authored a one-page PhD thesis: a solution to a longstanding problem in brainwave analysis.
